Brands: Anafranil · Clomipramine Hydrochloride
Average across 49 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Alembic Pharmaceuticals Limited | generic | 18 | SUPPLYING |
| Proficient Rx LP | repackager | 18 | SUPPLYING |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | generic | 12 | SUPPLYING |
| Micro Labs Limited | generic | 10 | SUPPLYING |
| Rising Pharma Holdings, Inc. | generic | 9 | SUPPLYING |
| NorthStar Rx LLC | relabeler | 9 | SUPPLYING |
| Leading Pharma, LLC | unknown | 8 | SUPPLYING |
| Aurobindo Pharma Limited | generic | 8 | SUPPLYING |
| Lifestar Pharma LLC | unknown | 6 | SUPPLYING |
| SpecGx LLC | unknown | 6 | SUPPLYING |
| Ajanta Pharma USA Inc. | unknown | 6 | SUPPLYING |
| Golden State Medical Supply, Inc. | repackager | 3 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 2 | SUPPLYING |
| American Health Packaging | repackager | 2 | SUPPLYING |
| Major Pharmaceuticals | relabeler | 2 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above the FDA acceptable intake limit. — Recalling firm: Zydus Pharmaceuticals (USA) Inc — Nationwide in the US
cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above the FDA acceptable intake limit. — Recalling firm: Zydus Pharmaceuticals (USA) Inc — Nationwide in the US
cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above the FDA acceptable intake limit. — Recalling firm: Zydus Pharmaceuticals (USA) Inc — Nationwide in the US
Superpotent Drug: Assay value found to be 110.6% in Chlomipramine Hydrocholoride capsules — Recalling firm: Leading Pharma, LLC — Nationwide within the United States
